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The preconceptional period provides an important oppor-
tunity to actively assess and treat tobacco use and to as-
sist parents-to-be in quitting permanently to avoid smoking-
related pregnancy and long-term health consequences.
The use of tobacco prior to conception is associated
with male impotence, conception delay, and primary as well
as secondary infertility. During pregnancy, tobacco use in-
creases theriskforspontaneous abortion, ectopic pregnancy,
low birth weight, SIDS, premature birth, and other fetal and
maternal complications [1]. Each year, almost one-half mil-
lion babies in the United States are born to mothers who re-
portsmokingduringpregnancy[2].Forsmokers,tobaccouse
continues to be the leading cause of morbidity and mortal-
ity in the United States, resulting in approximately 440,000
deaths per year [3].
Women smokers are at increased risk for cancer, cardio-
vascular disease, and pulmonary disease. Since 1987, lung
cancer has outpaced breast cancer as the leading cause of
cancer death among women, and exposure to environmen-
tal tobacco smoke (ETS) is a cause of lung cancer and
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coronary heart disease among lifetime nonsmokers. More-
over, infants born to women who are exposed to ETS during
pregnancy may also have increased health risks, including
small decrements in birth weight and slightly increased risk
for intrauterine growth retardation, compared with infants
born to women who were not exposed [1].
Despite all that is known about the devastating health
consequences of smoking, 20% of U.S. women smoked
cigarettes in 2003 [4] and 11.4% of women giving birth re-
ported smoking during their pregnancy [5]. It is encouraging
that 70% of smokers want to quit, and about two-ﬁfths quit
for at least a day every year [4]. To avoid early pregnancy
complications, women who smoke should be counseled to
quit before they become pregnant. In addition, smokers who
are partners of mothers-to-be should also be included in
any treatment plans given the strong association with part-
ner smoking and relapse [6] as well as concerns about ETS
exposure.
Treatmentfortobaccodependenceissafe,effective,avail-
able,andaffordable[7].The2000PublicHealthServicedoc-
ument, Treating Tobacco Use and Dependence: A Clinical
Practice Guideline [7], as well as the 2001 Centers for Dis-
ease Control and Prevention publication, Guide to Commu-
nity Preventive Services [8], both provide strong evidence-
based guidelines for treating smokers using a comprehen-
sive system that includes the 5A’s (a brief 5-step counseling
approach recommended by the 2000 PHS clinical practice
guideline for all smokers). These documents also provide
details of how reminder systems, telephone quitlines, de-
creased co-pays and costs of treatment, mass media cam-
paigns, smoke free environments and increased prices for
tobacco products support the cessation process [7, 8].
At the clinical level, every clinician providing preconcep-
tioncareshouldimplementatobaccotreatmentsystembased
on the 5 A’s and beginning with a systematic way to assess
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tobacco use. This evidence-based counseling approach in-
cludes asking every patient about tobacco use and, if they
smoke, advising them to quit, assessing willingness to quit,
assisting them in quitting, and arranging follow-up. Assist-
ing may include the offer of pharmacotherapies or additional
counseling, each of which doubles the quit rates in non-
pregnant adult populations [7]. The effectiveness of counsel-
ingincreasesastheintensity(numberandlengthofsessions)
increases. At present, seven ﬁrst-line FDA-approved medi-
cations are available: bupropion varenicline and ﬁve nico-
tinereplacementtherapies(gum,patch,lozenge,inhaler,and
nasal spray) [7]. Because the safety and efﬁcacy of pharma-
cotherapy during pregnancy has yet to be established, the
preconception period provides an excellent interval before
pregnancy to offer these effective adjuncts to quitting.
Once abstinent, patients should be followed to help avoid
relapse. For those smokers who are not willing to quit in the
near future, the PHS clinical practice guidelines recommend
the 5 R’s (relevance, risks, rewards, roadblocks, repetition)
to enhance patients’ motivation to quit smoking [7].
Clinical systems that provide tobacco-dependence treat-
mentshouldalsoincludearemindersystemtoalertproviders
to advise smokers in their practice [8]. This system might be
anelectronicmedicalrecordalertorsimplyastamporsticker
on the patient’s chart to indicate tobacco status - current, for-
mer,ornever.ThePHSguidelinealsorecommendsusingthe
305.1 ICD-10 code for tobacco dependence for billing pur-
poses[7].Thiscodealsomaybeusedbyhealth-caresystems
to monitor and improve the provision of effective treatment.
State quitlines provide an effective vehicle for telephone
counseling and can be accessed by calling 1-800-QUIT
NOW, a national portal number to refer tobacco users di-
rectlytotheirstatequitlinebasedontheirareacode.Asmall
number of states also provide over-the-counter medications
to eligible populations in conjunction with telephone coun-
seling. Another group of states (e.g., Maine, Massachusetts,
Oklahoma, Oregon, and Wisconsin) encourages providers
to fax referrals (with patient consent) to the state quitline,
which in turn proactively calls the smoker to begin counsel-
ing. Most quitlines send a “quit kit” to each caller.
With effective treatment, quit rates can be as high as
25%–30% in the general population [9]. Because many
women spontaneously quit upon learning about their
pregnancy—ranging from 11% to 28% in publicly insured
pregnant smokers to 40% to 65% in privately insured preg-
nant smokers [10], it is reasonable to expect that effective
preconception tobacco-dependence treatment could exceed
these rates, particularly if partners who smoke are treated
as well. Placing these cost-effective treatment systems
into preconception practice should not be insurmountable,
given the evidence, the affordability, the lessons learned
from other clinical tobacco-dependence systems, and the
availability of resources.
Available Resources for learning more about tobacco de-
pendence treatment:
 Treating Tobacco Use and Dependence. JAMA June, 28,
2000 (Summary article)
 Treating Tobacco Use and Dependence (full document).
Available at www.surgeongeneral.gov/tobacco.
 Agency for Health Care Research and Quality, patient and
provider materials. Available at www.ahrq.gov.
 The Guide to Community Preventive Services. Available
at www.thecommunityguide.org .
 Telephone Quitlines: A Resource for Develop-
ment, Implementation, and Evaluation. Available at
www.cdc.gov/tobacco.
 Smoke-Free Families provider, patient, and system mate-
rials. Available at www.smokefreefamilies.org.
 Environmental Protection Agency, smokefree home ban
materials. Available at www.epa.gov .
 March of Dimes at www.marchofdimes.com.
 Nicotine and Tobacco Research Journal supple-
ment: Helping Pregnant Women Quit Smok-
ing: Progress and Future Directions. Available at
http://www.ntrjournal.org/pregnancy.html.
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